Achieving patient satisfaction with multifocal IOLs
September 1st 2016Multifocal IOLs offer the potential to reduce spectacle dependence, but outcomes vary depending on optical design. Optimizing success and satisfaction depends on careful patient selection, thorough counseling, and good surgical technique.
Stressing the need for child vision screenings
August 25th 2016As parents and educators around the country are preparing this August for “Back to School” season, it is also Child’s Eye Health and Safety Month, serving as a reminder for parents, educators, and eye-care providers of the importance of vision screening for children. Plus, a new device may help specialists properly diagnose viral or bacteria pink eye in their pediatric patients.
Microstent approval makes big news in glaucoma world
August 6th 2016Clinicians will soon have another treatment option for their patients with non-severe primary open-angle glaucoma (POAG). A micro invasive glaucoma surgical (MIGS) device (CyPass Micro-Stent, Alcon) has been approved by the FDA for use in patients with mild-moderate PAOG in conjunction with cataract surgery.
Virtual eye health and vision examination: Why not?
August 6th 2016We really are at a crossroads in eye healthcare. Wouldn’t a virtual exam be ‘just as good’ as a trip to the eye doctor? To today’s busy consumer, how can we justify leisurely sitting in front of a computer or in a kiosk versus an in-office visit that takes sixty plus minutes and includes that awkward part – dilation?
Ophthalmology and death by poison
August 1st 2016My position is that murdering people with poison is a terrible thing, even if the victim is an annoying parent, mother-in-law, or department chair. It's morally wrong, plus the penalty would likely be severe (suspension of operating privileges or even being fired-unless, of course, you have tenure). Yet ophthalmologists certainly have the means to go around poisoning folks.
ABiC targets all sites of outflow resistance
August 1st 2016Ab-interno canaloplasty (ABiC) is a minimally invasive glaucoma surgery that accesses, catheterizes, and viscodilates all sites controlling aqueous outflow. When performed alone for uncontrolled glaucoma or with cataract surgery, it can result in reduced IOP and daily medication at follow-up through 12 months.
Portable device offers rapid high-definition meibomian gland imaging
August 1st 2016A new compact, portable device for rapid, high-definition meibomian gland imaging (LipiScan, TearScience) is an efficient screening tool for patients with complaints of dry eye and/or candidates for surgical procedures in which pre-existing dry eye could affect outcomes.
Second pivotal trial confirms IOP-lowering efficacy of first-in-class agent
August 1st 2016Results from a second pivotal trial investigating latanoprostene bunod 0.024% (LBN) are consistent with another identically designed study showing that not only is LBN non-inferior to timolol maleate 0.5% for lowering IOP, but it has significantly greater efficacy.